[7] PharmaCotherapia d.o.o., Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source., clinicaltrials.gov, Clinical trial registration NCT02637284, Dec
Other medical conditions and comorbidities Autoimmune diseases , diabetes , thyroid disorders , and chronic inflammatory states increase nerve sensitivity and reduce treatment response
References Glynn PC, Henney E, Hall IP (2002) The selective CXCR@ antagonist SB272844 blocks interleukin-8 and growth-related oncogene-alpha-mediated inhibition of spontaneous neutrophil apoptosis
This depletion can lead to anemia, and also an increased risk that their breastfed infants become vitamin deficient
How Much Is Your Vitamin B12 Deficiency